Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: gduck - my background
11
Feb 07, 2011 12:06PM
7
Feb 07, 2011 12:29PM
5
Feb 07, 2011 12:32PM
9
Feb 07, 2011 01:40PM
1
Feb 07, 2011 01:40PM
3
Feb 07, 2011 02:29PM
6
Feb 07, 2011 02:38PM
16
Feb 07, 2011 05:09PM
11
Feb 07, 2011 05:54PM
3
Feb 07, 2011 05:57PM

Thanks 'gduck' for sharing your background, especially for those who were unaware of it.

I understand your comments. They raise a question and that is:

Is it better to pursue the "smaller" companies now and keep a steady revenue stream and associated PR, holding the larger companies pending until what we expect and hope to be a positive US PTO ruling?"

A relatively small but steady revenue would help see us through the litigations, but at the expense of possibly higher license fees if wait until we prevail.

Conversely, waiting until the US PTO decision and assuming it is positive and all other TPL/Moore resolutions do not impact PTSC per se, then fees can be very much higher.

So it comes down to a small "keep alive" income or none until US PTO decides. What's the risk, as before, that more litigation will follow when we pursue new larger companies even with a positive US PTO outcome?

If PTSC prevails, it needs a board in place ready and capable to immediately and wisely handle the income. The recent Boards have not shown an ability to invest wisely.

If the US PTO rules against PTSC we will need a Board that can handle what, if any, assets remain.

5
Feb 07, 2011 07:08PM
4
Feb 07, 2011 07:36PM
1
Feb 07, 2011 08:16PM
5
Feb 07, 2011 08:34PM
6
Feb 07, 2011 09:17PM
Share
New Message
Please login to post a reply